Amphastar Pharmaceuticals
Amphastar Pharmaceuticals Inc is an American biopharmaceutical enterprise headquartered in Rancho Cucamonga, California. The company specializes in the research, development, manufacturing, and marketing of proprietary injectable, inhalation, and complex generic pharmaceutical products, focusing on critical care medications, insulin products, and respiratory treatments. Principal revenue is derived through wholesale manufacturing sales of specialized pharmaceutical products to hospitals, clinics, and pharmacies. Amphastar Pharmaceuticals is publicly listed on the Nasdaq Stock Market.
4 of the funds FundTelligence covers report a position in Amphastar Pharmaceuticals.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 4
Funds holding Amphastar Pharmaceuticals
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.08 % (full portfolio disclosed, October 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.06 % (full portfolio disclosed, December 2025)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)